# Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

> **NCT03692637** · EARLY_PHASE1 · UNKNOWN · sponsor: **Allife Medical Science and Technology Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer

## Interventions

- **BIOLOGICAL:** anti-Mesothelin Car NK Cells

## Key facts

- **NCT ID:** NCT03692637
- **Lead sponsor:** Allife Medical Science and Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2020-11
- **Final completion:** 2021-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692637, "Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03692637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*